BRAZILIAN HEALTH TECHNOLOGY ASSESSMENT BULLETIN: EDITORIAL PROCESS, DISSEMINATION STRATEGIES, CRITICAL APPRAISAL, AND INITIAL IMPACT

2012 ◽  
Vol 28 (1) ◽  
pp. 65-69 ◽  
Author(s):  
Marcus Tolentino Silva ◽  
Rosimary Terezinha de Almeida ◽  
Cintia Maria Gava ◽  
Taís Freire Galvão ◽  
Edina Mariko Koga da Silva ◽  
...  
Keyword(s):  
Health Technology Assessment ◽  
Technology Assessment ◽  
Critical Appraisal ◽  
Health Sector ◽  
Health Technology ◽  
Google Scholar ◽  
Editorial Process ◽  
Dissemination Strategy ◽  
Electronic Dissemination ◽  
Source Of Information

Objectives: This study reports on the Brazilian experience of developing a specialized bulletin, the Brazilian Health Technology Assessment Bulletin (BRATS), on health technology assessments (HTA).Methods: The editorial process, format, and dissemination strategy of the publication are presented. A critical appraisal of the available issues was made using the checklist for HTA reports of the International Network of Agencies for Health Technology Assessment. The initial impact was estimated based on a retrospective observational measurement of the types of publications that cite the bulletin as a source of information. The publications citing BRATS were identified using Google Scholar.Results: Since June 2008, fourteen issues of the bulletin have been produced. BRATS has not presented any significant limitation that would compromise generalizations of its results within the Brazilian context. The initial impact of the bulletin, however, has been small, which may be due to its exclusively electronic dissemination format and technical language. We found nine publications citing BRATS in Google Scholar.Conclusions: It is hoped that the bulletin will promote the continuity of HTA actions among health-sector managers and professionals in Brazil.

HEALTH TECHNOLOGY ASSESSMENT IN THE UNITED STATES

2002 ◽  
Vol 18 (2) ◽  
pp. 192-198 ◽  
Author(s):  
John M. Eisenberg ◽  
Deborah Zarin
Keyword(s):  
Health Technology Assessment ◽  
Technology Assessment ◽  
Health Sector ◽  
Health Technology ◽  
Healthcare Services ◽  
The United States ◽  
Public And Private ◽  
The Public ◽  
Policy Debates ◽  
Source Of Information

Governments may perform health technology assessment (HTA) in their roles as a regulator in the public interest, as a source of information for decision makers in the public and private sectors, and/or as a purchaser or provider of healthcare services. The U.S. government's roles in the health sector as a regulator, source of information, and purchaser and provider of services are influenced both by characteristics of that sector and by its stakeholders' effectiveness in influencing national health policy debates.

Improving ethics analysis in health technology assessment

2011 ◽  
Vol 27 (1) ◽  
pp. 64-70 ◽  
Author(s):  
Katherine Duthie ◽  
Kenneth Bond
Keyword(s):  
Health Technology Assessment ◽  
Technology Assessment ◽  
Health Technology ◽  
Legal Issues ◽  
Philosophical Analysis ◽  
Google Scholar ◽  
Theoretical Approaches ◽  
Ethical And Legal Issues ◽  
Alternative Approaches ◽  
Current Guidance

Objectives: The aim of this study was to critically examine the current guidance for conducting ethics analysis in health technology assessment (HTA) and to offer recommendations for how to improve this practice.Methods: MEDLINE, Philosopher's Index, and Google Scholar were searched for articles and reports using the keywords “ethics” and “health technology assessment” and related terms. Bibliographies of all relevant articles were also examined for additional references. A philosophical analysis of the existing guidance was conducted.Results: We offer three recommendations for improving ethics analysis in HTA. First, ethical and legal issues must be clearly separated so that all policy-relevant questions that the technology raises can be considered clearly and systematically. Second, analysts must make better use of ethics theory and discuss better how particular theoretical approaches and associated analytic tools are selected to make transparent which alternative approaches were considered and why they were rejected. Third, the necessity for philosophical expertise to adequately conduct ethics analysis needs to be acknowledged.Conclusions: To act on these recommendations for ethics analysis, we offer these three steps forward: acknowledge and use relevant expertise, further develop models for conducting and reporting ethics analyses, and make use of untapped resources in the literature.

scholarly journals Artificial Intelligence and Health Technology Assessment: Anticipating a New Level of Complexity (Preprint)

2020 ◽  
Author(s):  
Hassane Alami ◽  
Pascale Lehoux ◽  
Yannick Auclair ◽  
Michèle de Guise ◽  
Marie-Pierre Gagnon ◽  
...  
Keyword(s):  
Artificial Intelligence ◽  
Health Technology Assessment ◽  
Health System ◽  
Technology Assessment ◽  
Real World ◽  
Health Sector ◽  
Health Technology ◽  
System Transformation ◽  
Novel Technologies ◽  
Technical Performance

UNSTRUCTURED Artificial intelligence (AI) is seen as a strategic lever to improve access, quality, and efficiency of care and services and to build learning and value-based health systems. Many studies have examined the technical performance of AI within an experimental context. These studies provide limited insights into the issues that its use in a real-world context of care and services raises. To help decision makers address these issues in a systemic and holistic manner, this viewpoint paper relies on the health technology assessment core model to contrast the expectations of the health sector toward the use of AI with the risks that should be mitigated for its responsible deployment. The analysis adopts the perspective of payers (ie, health system organizations and agencies) because of their central role in regulating, financing, and reimbursing novel technologies. This paper suggests that AI-based systems should be seen as a health system transformation lever, rather than a discrete set of technological devices. Their use could bring significant changes and impacts at several levels: technological, clinical, human and cognitive (patient and clinician), professional and organizational, economic, legal, and ethical. The assessment of AI’s value proposition should thus go beyond technical performance and cost logic by performing a holistic analysis of its value in a real-world context of care and services. To guide AI development, generate knowledge, and draw lessons that can be translated into action, the right political, regulatory, organizational, clinical, and technological conditions for innovation should be created as a first step.

scholarly journals Health technology assessment development in China

2009 ◽  
Vol 25 (S1) ◽  
pp. 202-209 ◽  
Author(s):  
Yingyao Chen ◽  
David Banta ◽  
Zhiliu Tang
Keyword(s):  
Health Technology Assessment ◽  
Technology Assessment ◽  
Policy Making ◽  
Health Sector ◽  
Health Technology ◽  
Policy Makers ◽  
Great Opportunity ◽  
Assessment Development ◽  
The Past ◽  
Insurance Benefit

Objectives: This study is to review health technology assessment (HTA) development in China during the past two decades, and to facilitate further development of HTA and its integration into policy making.Methods: The study depends very much on the extensive experiences of the authors in involvement of HTA in China. In addition, literature review and Web site searching have been used to trace the process of growth of HTA in China.Results: With its rapid economic development, the Chinese health system has had many achievements in the past 30 years. However, there are some weaknesses that have developed during this period. HTA is traced back to the early 1990s in China. First, HTA knowledge transfer and establishment of HTA units were effective ways to develop HTA in China. By the end of 1990s, the policy makers of the Ministry of Health (MoH) made efforts to merge HTA with policy making to improve the quality and efficiency of health care. The main government authorities related to health technology are the State Food and Drug Administration, the Ministry of Labor and Social Security, and the MoH. Their involvements in HTA are varied.Conclusion: A technology licensure mechanism based on HTA, including technology permission for use, institution licensure, and workforce licensure, is being gradually carried out by the MoH in China. Moreover, HTA can play an important role in technology market entry, insurance benefit coverage, formulary, clinical pathway, reimbursement, and so on. There is a great opportunity for HTA to be an important part of health reform, especially to help policy makers within the health sector to make difficult decisions.

COMPARISON OF LITERATURE SEARCHES ON QUALITY AND COSTS FOR HEALTH TECHNOLOGY ASSESSMENT USING THE MEDLINE AND EMBASE DATABASES

1999 ◽  
Vol 15 (2) ◽  
pp. 297-303 ◽  
Author(s):  
Leigh-Ann Topfer ◽  
Antoni Parada ◽  
Devidas Menon ◽  
Hussein Noorani ◽  
Christine Perras ◽  
...  
Keyword(s):  
Health Technology Assessment ◽  
Technology Assessment ◽  
Time Lag ◽  
Health Technology ◽  
The Other ◽  
Level Of Evidence ◽  
Literature Searches ◽  
Pertinent Information ◽  
The Cost ◽  
Source Of Information

Biomedical databases are an important source of information for health technology assessment. However, there is considerable variation in the costs of accessing commercial databases. We sought to measure the quality, amount of overlap, and costs of information retrieved from two of the main database sources — MEDLINE and EMBASE. Librarians at two health technology assessment agencies ran a total of eight literature searches on various medical technologies, using both databases. All search results were independently reviewed by two researchers. The researchers were asked to identify relevant references and to rank each of these according to a level of evidence scale. The results were tabulated to show the number of references identified by each database, the number of relevant references ranked by level of evidence, and the number of these references that were unique to one or the other database. The cost of retrieving references from each source was also calculated. Each database contained relevant references not available in the other. Because of the longer time lag for indexing in MEDLINE, many of the references that originally appeared to be unique to EMBASE were subsequently available in MEDLINE as well. Since our study was conducted, MEDLINE has been made available worldwide, free of charge, via the Internet. Hence, the cost difference between the databases is now even greater. However, notwithstanding the costs, it appears that literature searches that rely on only one or the other database will inevitably miss pertinent information.

scholarly journals HTA and MCDA solely or combined? The case of priority-setting in Colombia

2018 ◽  
Vol 16 (S1) ◽  
Author(s):  
Héctor E. Castro ◽  
Ornella Moreno-Mattar ◽  
Juan C. Rivillas
Keyword(s):  
Decision Making ◽  
Health Technology Assessment ◽  
Priority Setting ◽  
Technology Assessment ◽  
Ad Hoc ◽  
Health Sector ◽  
Health Technology ◽  
Main Body ◽  
Healthcare Decision Making ◽  
Potential Benefits

Abstract Background All healthcare systems face problems of justice and efficiency related to setting priorities for allocating limited financial resources. Therefore, explicit decision-making in healthcare depicted as a continuum from evidence generation to deliberation and communication of the decision made, needs to be transparent and fair. Nevertheless, priority-setting in many parts of the world remains being implicit and ad-hoc process. Health Technology Assessment (HTA) and Multi-Criteria Decision Analysis (MCDA) have emerged as policy tools to assist informed decision-making. Both, MCDA and HTA have pros and cons. Main body Colombia experienced an important institutional transformation after the establishment of the Health Technology Assessment Institute in 2012. This paper briefly presents the current challenges of the Colombian health system, the general features of the new health sector reform, the main characteristics of HTA in Colombia and the potential benefits and caveats of incorporating MCDA approaches into the decision-making process. Conclusion Structured and objective consideration of the factors that are both measurable and value-based in an open and transparent manner may be feasible through combining HTA and MCDA in contexts like Colombia. Further testing and validation of HTA and MCDA solely or combined in LMICs are needed to advance these approaches into healthcare decision-making worldwide.

Sign in / Sign up

Export Citation Format

Share Document